AVATR’s Series C Financing

Fangda advised AVATR on the deal. AVATR completed its Series C financing, with the total investment amount exceeding RMB 11 billion. According to the public information,...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Shanghai Henlius Biotech’s Collaboration and License Agreement with Palleon Pharmaceuticals

Fangda advised Shanghai Henlius Biotech, Inc. on the deal. Shanghai Henlius Biotech, Inc. (“Henlius”, 2696.HK) secured a collaboration and license agreement with Palleon Pharmaceuticals (“Palleon”) to...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here